Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction
Table 2
Laboratory findings of patients according to the cystatin C-based estimate of GFR on day 12 after STEMI.
Indicators
GFR (CKD-EPI 2012) by cystatin ≥60,
GFR (CKD-EPI 2012) by cystatin <60,
Total cholesterol, mmol/L
5.17 (4.26; 6.20)
5.39 (4.44; 6.20)
0.84
Glycemia, mmol/L
7.80 (6.70; 10.80)
8.00 (6.40; 12.42)
0.42
Blood creatinine on admission, mcmol/L
93.00 (81.00; 115.00)
103.00 (89.50; 124.00)
0.04
GFR CKD-EPI on admission, mL/min/1.73 m2
69.79 (58.37; 79.82)
59.04 (47.88; 477.23)
0.009
GFR CKD-EPI at discharge, mL/min/1.73 m2
68.46 (64.05; 81.39)
61.39 (53.36; 79.86)
0.06
Blood creatinine at discharge, mcmol/L
97.00 (84.00; 106.00)
98.00 (82.50; 117.50)
0.38
Galectin concentration on the 1st day, ng/mL
28.72 (23.46; 31.30)
32.14 (26.45; 34.90)
0.08
Galectin concentration on the 12th day, ng/mL
15.27 (7.24; 24.30)
18.28 (9.0; 31.75)
0.04
Values are (%) or median (25th; 75th percentile). value for differences between groups (). Note: CAG, coronary angiography; GFR, glomerular filtration rate.
